Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

According to an ETNow poll, the drugmakers consolidated revenue for the quarter ended December is seen rising 12.5% on-year ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India ...

The Indian-based pharma company stated that it expects the deal to be completed during the first quarter of 2023.

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the ...

iBeat Analytics Ibeat 1 Year HTTPS To track article's statistics The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate ...

Sun Pharmaceutical Industries Ltd. shares inched down 0.10% to 1,039.95 Indian rupees Wednesday, on what proved to be an ...